Safety and tolerability study in adults with cold agglutinin disease previously treated with SAR445088 or never treated with SAR445088

Trial Identifier:	LTS16637
Sponsor:	Bioverativ, a Sanofi Company
Start Date:	March 2021
Primary Completion Date:	March 2025
Study Completion Date:	March 2025
Condition:	Anemia

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

Language	Description

Stay informed about new Trial Results Summaries with our email notification service

Trial Locations

Country	Location
Germany	Germany
Italy	Italy
Netherlands	Netherlands
Norway	Norway
United Kingdom	United Kingdom

Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.